300 million vaccine doses – and with the option to buy an additional 100 million doses if needed.
This is the vaccine contract, which The European Commission has entered into an agreement with AstraZeneca on behalf of Denmark and the othersEU countries.
But AstraZeneca has had huge problems delivering the doses ordered by member states. In addition, there have been problems with serious side effects. Now informsEuropean Commission that it will not take advantage of the opportunity to purchase an additional 100 million doses.
The missing doses have in recent months created great anger and frustration in EU , and earlier in the day several wrotemedia , thatThe European Commission is preparing for a lawsuit against the British-Swedish company.
But according to a spokesperson, no final decision has been made about it yet.